Autoimmunity induced by interferon-α therapy for chronic viral hepatitis
- 30 June 1999
- journal article
- review article
- Published by Elsevier BV in Biomedicine & Pharmacotherapy
- Vol. 53 (5-6), 242-254
- https://doi.org/10.1016/s0753-3322(99)80095-x
Abstract
No abstract availableKeywords
This publication has 126 references indexed in Scilit:
- Interferon-α therapy May induce insulin autoantibody development in patients with chronic viral hepatitisDigestive Diseases and Sciences, 1996
- Liver cytosolic 1 antigen-antibody system in type 2 autoimmune hepatitis and hepatitis C virus infection.Gut, 1995
- Anti-neutrophil antibodies in chronic hepatitis and the effect of α-interferon therapyJournal of Hepatology, 1993
- Latent autoimmune thyroid disease in patients with chronic HCV hepatitisJournal of Hepatology, 1992
- Lupus-like autoimmune disease induced by interferon therapy for myeloproliferative disordersClinical Immunology and Immunopathology, 1992
- Systemic lupus erythematosus in a child receiving long-term interferon therapyThe Journal of Pediatrics, 1992
- Clinical Toxicity of Interleukin-2Drug Safety, 1992
- Thyroid dysfunction and liver injury following alpha-interferon treatment of chronic viral hepatitisDigestive Diseases and Sciences, 1991
- Primary hypothyroidism associated with interleukin-2 and interferon alpha-2 therapy of melanoma and renal carcinomaEuropean Journal of Cancer and Clinical Oncology, 1990
- Cutaneous vasculitis associated with interferonEuropean Journal of Cancer and Clinical Oncology, 1983